Drug Shortage Report for VYNDAQEL
| Report ID | 152609 |
| Drug Identification Number | 02495732 |
| Brand name | VYNDAQEL |
| Common or Proper name | VYNDAQEL |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 4X30 BLST |
| ATC code | N07XX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-01-12 |
| Estimated end date | 2022-03-31 |
| Actual end date | 2022-03-01 |
| Shortage status | Resolved |
| Updated date | 2022-03-02 |
| Company comments | On preventive allocation. Shortage avoided. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-03-02 | English | Compare |
| v5 | 2022-03-01 | French | Compare |
| v4 | 2022-03-01 | English | Compare |
| v3 | 2022-01-13 | English | Compare |
| v2 | 2022-01-12 | French | Compare |
| v1 | 2022-01-12 | English | Compare |
Showing 1 to 6 of 6